Researchers discover a gene which may reveal how well a person is likely to respond to SSRI antidepressants.
Increased levels of serotonin transporters in the amygdala may explain why some people are more prone to anxiety than others.
Researchers use brain wave recordings to successfully predict patient response to common antidepressants.
The SSRI sertraline (Zoloft), if taken while pregnant, can result in birth defects caused by the drug damaging a cell's genetic information. Researchers report one potential way to counter the effect is with specific antioxidants.
Researchers report early interventions can help accelerate recovery for PTSD, but results may not be sustained.
SSRI's, ketamine, and tricyclic antidepressants all bind with TrkB. The findings challenge the roles serotonin and glutamate receptors play in the effects of antidepressant medications.
Researchers identify a molecular pathway which accelerates the time taken for antidepressants to work in mouse models.
Researchers find no evidence that a serotonin related gene alters the impact stress has on depression.
The placebo effect combined with dopamine levels can determine whether symptoms of depression and social anxiety will improve in patients prescribed SSRI antidepressants. Researchers found the positive effect of the medications was four times higher in patients with high expectations the treatment would work compared to those with lower expectations.
Using a mini-brain model, researchers report the popular SSRI antidepressant Paroxetine can induce brain cell developmental abnormalities that could lead to adverse effects in children.
Researchers suggest serotonin metabolism in the pineal gland could play a role in the underlying cause of depression. The findings were based on biochemical changes which were seen to be in association with improvements in depression.
The antipsychotic medication clozapine can trigger severe obsessive-compulsive symptoms (OCS) in patients. Adding aripiprazole can help manage clozapine-associated OCS.
